Metabolic Disorders Are Associated With Drug-Induced Liver Injury During Antituberculosis Treatment: A Multicenter Prospective Observational Cohort Study in Korea

BACKGROUND: Drug-induced liver injury (DILI) may lead to the discontinuation of antituberculosis (anti-TB) treatment (ATT). Some studies have suggested that metabolic disorders increase the risk of DILI during ATT. This study aimed to identify risk factors for DILI, particularly metabolic disorders,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jihye, Kim, Ju Sang, Kim, Hyung Woo, Kim, Yong Hyun, Jung, Sung Soo, Kim, Jin Woo, Oh, Jee Youn, Lee, Heayon, Kim, Sung Kyoung, Kim, Sun-Hyung, Lyu, Jiwon, Ko, Yousang, Kwon, Sun Jung, Jeong, Yun-Jeong, Kim, Do Jin, Koo, Hyeon-Kyoung, Jegal, Yangjin, Kyung, Sun Young, An, Tai Joon, Min, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468151/
https://www.ncbi.nlm.nih.gov/pubmed/37654787
http://dx.doi.org/10.1093/ofid/ofad422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468151/
https://www.ncbi.nlm.nih.gov/pubmed/37654787
http://dx.doi.org/10.1093/ofid/ofad422

Ejemplares similares